Paraneoplastic Syndrome: Causes & Treatment
Paraneoplastic syndrome refers to symptoms triggered by a malignant tumor without the tumor directly invading the affected tissue.
Things worth knowing about "Paraneoplastic Syndrome"
Paraneoplastic syndrome refers to symptoms triggered by a malignant tumor without the tumor directly invading the affected tissue.
What is Paraneoplastic Syndrome?
Paraneoplastic syndrome (PNS) is an umbrella term for symptoms and disorders that are indirectly caused by a malignant tumor. Unlike direct tumor effects such as pain from compression or metastases, these symptoms arise from substances secreted by the tumor or from an abnormal immune response that mistakenly attacks the body's own tissues. The syndrome can affect almost any organ system and frequently appears before the tumor itself is diagnosed, making it an important clinical warning sign.
Causes and Mechanisms
Paraneoplastic syndromes develop through two primary mechanisms:
- Hormonal or biochemical: Some tumors produce hormones or hormone-like substances (ectopic hormone production) that trigger effects not normally associated with the tissue of origin. For example, lung tumors may secrete antidiuretic hormone (ADH) or adrenocorticotropic hormone (ACTH).
- Immunological: The immune system generates antibodies against tumor antigens. These antibodies mistakenly attack healthy body tissue, especially the nervous system. This leads to what is known as paraneoplastic neurological syndromes.
Tumor types commonly associated with paraneoplastic syndromes include:
- Small cell lung carcinoma
- Breast cancer (mammary carcinoma)
- Ovarian carcinoma
- Thymoma (tumor of the thymus)
- Hodgkin lymphoma
Symptoms
The symptoms of paraneoplastic syndrome are highly diverse, as virtually every organ system can be involved. The most common manifestations include:
Neurological Symptoms
- Paraneoplastic encephalomyelitis: Memory impairment, confusion, personality changes
- Cerebellar degeneration: Balance disorders, loss of coordination (ataxia), double vision
- Polyneuropathy: Tingling, numbness, or weakness in the limbs
- Lambert-Eaton syndrome: Muscle weakness, particularly of the legs
Endocrine Symptoms
- Cushing syndrome due to ectopic ACTH production: weight gain, high blood pressure, elevated blood sugar
- Syndrome of inappropriate ADH secretion (SIADH): Hyponatremia (low sodium), nausea, confusion
- Hypercalcemia from PTHrP production: bone pain, fatigue, kidney problems
Hematological and Dermatological Symptoms
- Thrombosis and increased bleeding tendency
- Acanthosis nigricans (dark, velvety skin thickening)
- Dermatomyositis (muscle inflammation with skin involvement)
Diagnosis
Diagnosing paraneoplastic syndrome can be challenging because symptoms are often nonspecific and can mimic many other conditions. The following investigations are commonly used:
- Blood tests: Detection of paraneoplastic antibodies (e.g., anti-Hu, anti-Yo, anti-NMDAR), hormone measurements (ACTH, ADH, PTHrP), electrolytes (sodium, calcium)
- Imaging: CT, MRI, or PET-CT to identify the underlying tumor
- Lumbar puncture (spinal tap): Examination of cerebrospinal fluid if neurological involvement is suspected
- Electrophysiology: Nerve conduction studies for neuropathies
- Biopsy: Tissue sampling to determine tumor type
Importantly, if typical paraneoplastic antibodies are detected, a thorough search for an underlying tumor must be initiated, even if no tumor has yet been identified.
Treatment
The most important treatment is addressing the underlying tumor. Successful tumor therapy (surgery, chemotherapy, radiation, or immunotherapy) can significantly improve or completely resolve paraneoplastic symptoms.
Additional treatment options include:
- Immunosuppressive therapy: Corticosteroids, plasmapheresis (blood purification), intravenous immunoglobulins (IVIG), or rituximab for immune-mediated forms
- Symptomatic treatment: Physical therapy, pain management, electrolyte correction depending on the affected organ systems
- Hormonal countermeasures: For example, mineralocorticoid antagonists in ACTH-excess-related Cushing syndrome
Prognosis depends greatly on tumor type, disease stage, and which organ systems are affected. Early recognition and treatment significantly improve outcomes.
References
- Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurology. 2008;7(4):327-340.
- Graus F et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery & Psychiatry. 2004;75(8):1135-1140.
- National Cancer Institute (NCI). Paraneoplastic Syndromes. U.S. Department of Health and Human Services, 2023.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.